Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:CASNumber |
1353552-97-0
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
GlaxoSmithKline
|
| gptkbp:hasMolecularFormula |
C22H19N5O2S
|
| https://www.w3.org/2000/01/rdf-schema#label |
solcitinib
|
| gptkbp:intendedUse |
autoimmune diseases
|
| gptkbp:IUPACName |
N-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)phenyl)thiazol-2-yl)acetamide
|
| gptkbp:mechanismOfAction |
JAK1 inhibitor
|
| gptkbp:synonym |
GSK2586184
|
| gptkbp:bfsParent |
gptkb:Janus_kinases
|
| gptkbp:bfsLayer |
8
|